This enduring activity is a dialogue between multidisciplinary experts and aims to improve clinicians’ knowledge and competence in accurately diagnosing extrapulmonary neuroendocrine carcinoma and applying emerging evidence on DLL3-targeting T-cell engagers to optimize evidence-based treatment strategies. As a result of this educational activity, learners will be better able to: 1. Differentiate extrapulmonary neuroendocrine carcinoma (EP-NEC) from extrapulmonary neuroendocrine tumors (EP-NETs); 2. Identify diagnostic and pathological approaches to improve the recognition and accurate classification of EP-NEC; 3. Evaluate emerging clinical data on DLL3-targeting bispecific T-cell engager (TCE) agents in the treatment of EP-NEC; and, 4. Formulate evidence-based strategies to integrate DLL3-targeting bispecific TCE therapies into evolving treatment paradigms for EP-NEC. Learners have access to downloadable materials for future use in practice.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 27 Trinity Place, Suite 185
Pricing
99% of listed courses are free
156 of 157 courses listed here are free.
Collected from the provider’s public pages
Specialties served/covered
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Critical Care Medicine
- Dermatology
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General Internal Medicine
- General Pediatrics
- General Surgery
- Gynecologic Oncology
- Hematology
- Infectious Disease
- Interventional Cardiology
- Maternal-Fetal Medicine
- Medical Oncology
- Nephrology
- Neurocritical Care
- Neurology
- Neuromuscular Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Pediatric Gastroenterology
- Pediatric Infectious Diseases
- Pulmonary Disease
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Transplant Hepatology
- Urological Oncology
- Urology
- Vascular Neurology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pathology & Lab
- Pediatrics
- Primary care
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Microlearning
- Credit · Up to 0.5 credits
- Commercial Support
-
ReleasedJun 12, 2026
-
Last day to claim creditJun 12, 2027 8 months left
-
Physicians’ Education Resource Live Tumor Board: Exploring Novel Targets and Breakthrough Treatment Strategies in Extrapulmonary Neuroendocrine Carcinomas
-
PVI, PeerView Institute for Medical Education From Poor Prognosis to Emerging Clinical Potential A Visual Journey of Targeted Therapy Innovation in Extrapulmonary Neuroendocrine Carcinomas
-
Plexus Communications +1 Navigating the Expanding NET Treatment Arsenal: Key Advances in Targeted Therapy & Nuclear Medicine
-
Answers in CME Inc. (AiCME) Getting The Diagnosis Right in EP-NEC: Pathology as the Gateway to Emerging Therapeutic Targets
-
Answers in CME Inc. (AiCME) Breaking News in SCLC: Expert Insights on B7-H3 Directed ADCs From Recent Congresses
-
Answers in CME Inc. (AiCME) From Evidence to Action: Expert Dialogues on the Evolving Role of Immunotherapy in Basal Cell Carcinoma
